Details of Disease

General Information of Disease (ID: DISB3X5A)

• Disease Name: Nervous system inflammation
• Synonyms: central nervous system inflammation; inflammation of central nervous system; encephalitis and/or myelitis; encephalitis &/or myelitis
• Disease Class: 1D0Y: CNS non-viral infection
• Definition: Inflammation of the brain and the spinal cord.
• Disease Hierarchy:
  DIS184KT: Skin inflammation
  DISEP2HK: Central and peripheral nervous disease
  DISWD40R: Disease
  DISB3X5A: Nervous system inflammation
• ICD Code: ICD-11: ICD-11: 1D0Y
• Disease Identifiers:
  MONDO ID: MONDO_0005156
  MESH ID: D004679
  UMLS CUI: C0014070
  MedGen ID: 8603
  SNOMED CT ID: 62950007

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 3 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
5-LO (pain/neuro-inflammation), St Charles Pharmaceuticals	DMF2OT4	Investigative	NA	[1]
AV-1013	DM7L37I	Investigative	NA	[1]
KR-31360	DMUR8MP	Investigative	NA	[1]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 176 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ABL2	TT1A6HL	Limited	Biomarker	[2]
ADRA2A	TTWG9A4	Limited	Biomarker	[3]
AOC3	TT7HC21	Limited	Altered Expression	[4]
ARRB1	TTMVD4A	Limited	Altered Expression	[5]
ARRB2	TT8SO2I	Limited	Biomarker	[6]
BACE1	TTJUNZF	Limited	Biomarker	[7]
C3AR1	TTI6B3F	Limited	Biomarker	[8]
CBL	TT7QT13	Limited	Biomarker	[9]
CBLB	TTHRAIJ	Limited	Biomarker	[10]
CD2	TTJDUNO	Limited	Biomarker	[11]
CD274	TT8ZLTI	Limited	Biomarker	[12]
CD40LG	TTIJP3Q	Limited	Biomarker	[13]
CD83	TTT9MRQ	Limited	Biomarker	[14]
CDK19	TTNABU9	Limited	Biomarker	[15]
CHAT	TTKYFSB	Limited	Biomarker	[16]
CSNK2A1	TTER6YH	Limited	Biomarker	[17]
DGAT1	TT0GV3R	Limited	Biomarker	[18]
DRD5	TTS2PH3	Limited	Biomarker	[19]
FCGR2B	TT5RWKQ	Limited	Altered Expression	[20]
FTH1	TT975ZT	Limited	Altered Expression	[21]
GALR2	TTBPW3J	Limited	Altered Expression	[22]
GCK	TTDLNGZ	Limited	Biomarker	[23]
GOT1	TTU507L	Limited	Biomarker	[24]
GP6	TTTJUVZ	Limited	Biomarker	[25]
GPR17	TTMPART	Limited	Biomarker	[26]
HRH1	TTTIBOJ	Limited	Biomarker	[27]
HRH2	TTQHJ1K	Limited	Biomarker	[28]
HRH3	TT9JNIC	Limited	Genetic Variation	[29]
IKZF2	TTKT5NV	Limited	Altered Expression	[30]
IL11RA	TTZPLJS	Limited	Biomarker	[31]
IL17D	TTC5LTG	Limited	Biomarker	[32]
ILDR2	TT0R2QD	Limited	Biomarker	[33]
IRAK3	TTBPJOK	Limited	Altered Expression	[34]
KCNK3	TTGR91N	Limited	Altered Expression	[35]
KCNK9	TTL4FMB	Limited	Altered Expression	[35]
LIFR	TTID542	Limited	Altered Expression	[36]
LY75	TTG180Q	Limited	Biomarker	[37]
MAP4K3	TTI0AHJ	Limited	Biomarker	[23]
MC1R	TT0MV2T	Limited	Biomarker	[38]
NOD1	TTYSRXM	Limited	Altered Expression	[39]
P2RY12	TTZ1DT0	Limited	Altered Expression	[40]
PDE7A	TT1BC3A	Limited	Altered Expression	[41]
PKN2	TTTHO0M	Limited	Genetic Variation	[42]
PPID	TTNAFOU	Limited	Biomarker	[43]
PPIF	TTRFQTB	Limited	Biomarker	[43]
PRKCQ	TT1MS7X	Limited	Biomarker	[44]
RGMA	TTURJV4	Limited	Biomarker	[45]
SIRPA	TTBRJS9	Limited	Biomarker	[46]
SLAMF6	TTSIYJ6	Limited	Biomarker	[47]
SLC18A3	TTV8KWS	Limited	Altered Expression	[48]
SLC6A1	TTPRKM0	Limited	Biomarker	[49]
SLC6A11	TT8RXO5	Limited	Altered Expression	[50]
SLC9A3	TTFZVPO	Limited	Biomarker	[51]
SPP1	TT8ME6I	Limited	Biomarker	[52]
TIAM1	TTNU6I5	Limited	Altered Expression	[53]
TNFRSF13B	TTL9OD4	Limited	Biomarker	[54]
VSIR	TT51SK8	Limited	Altered Expression	[55]
MADCAM1	TTBD6I7	Disputed	Biomarker	[56]
CD24	TTCTYNP	moderate	Biomarker	[57]
CRYAB	TT7RUHB	moderate	Biomarker	[58]
ITGAM	TTB69FJ	moderate	Biomarker	[59]
MS4A1	TTUE541	moderate	Biomarker	[60]
P2RX7	TT473XN	moderate	Altered Expression	[40]
PDXP	TT9UYG4	moderate	Biomarker	[61]
PRDX5	TTLPJWH	moderate	Biomarker	[61]
PTPRC	TTUS45N	moderate	Altered Expression	[62]
TNFRSF1B	TT63WSF	moderate	Altered Expression	[63]
TSPO	TTPTXIN	moderate	Genetic Variation	[64]
VCAM1	TTHCEF6	moderate	Altered Expression	[65]
ACKR1	TTKY2NS	Strong	Biomarker	[66]
ADCYAP1R1	TT5OREU	Strong	Biomarker	[67]
AICDA	TTKRTP6	Strong	Biomarker	[68]
AIF1	TT12MEP	Strong	Biomarker	[69]
ALCAM	TT2AFT6	Strong	Biomarker	[70]
ARG1	TT7ZQEV	Strong	Biomarker	[71]
ARG2	TTV1AG6	Strong	Altered Expression	[72]
C5	TTKANGO	Strong	Biomarker	[73]
C5AR1	TTHXFA1	Strong	Biomarker	[73]
CCL22	TTBTWI1	Strong	Biomarker	[74]
CCL3	TT8I4WB	Strong	Altered Expression	[75]
CCR2	TTFZYTO	Strong	Biomarker	[76]
CCR6	TTFDB30	Strong	Altered Expression	[77]
CCR9	TTIPS8B	Strong	Biomarker	[56]
CD200	TT0BE68	Strong	Biomarker	[78]
CD28	TTQ13FT	Strong	Biomarker	[79]
CD40	TT1ERKL	Strong	Biomarker	[13]
CD47	TT28S46	Strong	Biomarker	[80]
CD58	TT5KSBY	Strong	Biomarker	[81]
CD86	TT53XHB	Strong	Biomarker	[82]
CLEC12A	TT70N8V	Strong	Biomarker	[83]
CMKLR1	TT4UGZL	Strong	Biomarker	[84]
CTSC	TT4H0V2	Strong	Biomarker	[85]
CTSE	TTLXC4Q	Strong	Biomarker	[86]
CTSH	TT3G406	Strong	Biomarker	[87]
CX3CR1	TT2T98G	Strong	Biomarker	[88]
CXCL13	TT0NIZ1	Strong	Biomarker	[89]
CXCR2	TT30C9G	Strong	Biomarker	[90]
CYBB	TT5T8MR	Strong	Genetic Variation	[91]
CYP46A1	TT4EB85	Strong	Biomarker	[92]
DPYSL2	TTZCW3T	Strong	Altered Expression	[93]
DUSP10	TTF3RJ0	Strong	Altered Expression	[94]
EGFL7	TT7WD0H	Strong	Altered Expression	[95]
ENTPD1	TTYM8DJ	Strong	Biomarker	[71]
FOXP3	TT1X3QF	Strong	Biomarker	[96]
GAP43	TTSGLN5	Strong	Altered Expression	[97]
GFAP	TTI6FFX	Strong	Biomarker	[98]
GJB1	TTSJIRP	Strong	Biomarker	[99]
GJB6	TTAU8SJ	Strong	Biomarker	[100]
GPI	TT19JIZ	Strong	Biomarker	[101]
GPR183	TTME5YJ	Strong	Biomarker	[102]
GRIA4	TTPJR0G	Strong	Biomarker	[103]
GRM1	TTVBPDM	Strong	Altered Expression	[104]
GRM4	TTICZ1O	Strong	Biomarker	[103]
GRM5	TTHS256	Strong	Altered Expression	[104]
HNRNPA1	TTPJ9XK	Strong	Biomarker	[105]
IFNAR1	TTSYFMA	Strong	Biomarker	[106]
IFNB1	TT4TZ8J	Strong	Biomarker	[107]
IL11	TTGUYTR	Strong	Biomarker	[108]
IL17F	TT2B6PS	Strong	Biomarker	[109]
IL23R	TT6H4QR	Strong	Biomarker	[110]
IL37	TTQTX98	Strong	Biomarker	[111]
IL7R	TTAWI51	Strong	Biomarker	[112]
IRF3	TTYR7OH	Strong	Altered Expression	[87]
ITGA4	TTJMF9P	Strong	Biomarker	[113]
ITGAL	TT48WR6	Strong	Biomarker	[114]
ITGB2	TTIJWR7	Strong	Biomarker	[114]
KLK6	TTLPF4X	Strong	Biomarker	[115]
KLK8	TTH5MRS	Strong	Biomarker	[116]
LANCL1	TTZW8NS	Strong	Biomarker	[111]
LBP	TTVQJLY	Strong	Altered Expression	[117]
LINGO1	TTZYQ80	Strong	Biomarker	[118]
LTBR	TTFO0PM	Strong	Biomarker	[119]
MBTPS1	TTNSM2I	Strong	Biomarker	[120]
MMP12	TTXZ0KQ	Strong	Biomarker	[121]
NCF1	TTZ4JC3	Strong	Altered Expression	[21]
NR4A1	TTMXE2Q	Strong	Biomarker	[122]
NR4A2	TT9HKN3	Strong	Altered Expression	[123]
NTF3	TTZHKV9	Strong	Altered Expression	[124]
NTN1	TT0AH4L	Strong	Altered Expression	[125]
P2RX4	TT1NLOA	Strong	Altered Expression	[40]
PCSK1	TTED9LZ	Strong	Biomarker	[126]
PDE4B	TTVIAT9	Strong	Biomarker	[127]
PECAM1	TT4EZB2	Strong	Altered Expression	[128]
PLA2G4A	TTT1JVS	Strong	Biomarker	[129]
PRMT5	TTR1D7X	Strong	Biomarker	[130]
PROC	TTZUXYS	Strong	Altered Expression	[131]
PSMB9	TTOUSTQ	Strong	Altered Expression	[132]
PTBP1	TTWMX0U	Strong	Biomarker	[105]
PTGES	TTYLQ8V	Strong	Biomarker	[133]
RIPK2	TTCQ2E5	Strong	Biomarker	[134]
RPSA	TTLUW5B	Strong	Biomarker	[111]
SLC7A11	TTBZMIO	Strong	Altered Expression	[135]
SMPD1	TTJTM88	Strong	Biomarker	[136]
SORT1	TTRX9AV	Strong	Biomarker	[137]
SRR	TTZFUY6	Strong	Biomarker	[138]
STK38	TT27XFN	Strong	Biomarker	[139]
SYVN1	TT8XKYM	Strong	Biomarker	[140]
TDO2	TTXNCBV	Strong	Altered Expression	[141]
TLR8	TT8CWFK	Strong	Altered Expression	[142]
TNFRSF4	TTL31H0	Strong	Biomarker	[143]
TNFSF13B	TTWMIDN	Strong	Biomarker	[54]
TRPM4	TTJ2HKA	Strong	Biomarker	[144]
TRPM8	TTXDKTO	Strong	Biomarker	[145]
ULK1	TT4D7MJ	Strong	Biomarker	[146]
VEGFB	TTPJQHE	Strong	Biomarker	[147]
CD52	TTQT5S9	Definitive	Altered Expression	[148]
CHRM3	TTQ13Z5	Definitive	Genetic Variation	[64]
IL7	TT8FRMO	Definitive	Altered Expression	[149]
IL9	TT0JTFD	Definitive	Biomarker	[150]
LIF	TTGZ5WN	Definitive	Biomarker	[151]
MALT1	TTCI81G	Definitive	Altered Expression	[152]
RTN4R	TTVRZUO	Definitive	Biomarker	[153]
S1PR1	TT9JZCK	Definitive	Genetic Variation	[154]
SGK1	TTTV8EJ	Definitive	Altered Expression	[155]
SPHK1	TTOHFIY	Definitive	Biomarker	[156]
TLR7	TTRJ1K4	Definitive	Biomarker	[157]

This Disease Is Related to 6 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
KCNK2	DTENHUP	Limited	Biomarker	[158]
SLC22A17	DTXI9E6	Limited	Altered Expression	[159]
SLC6A13	DTX8KP0	Limited	Altered Expression	[50]
SLC7A10	DTVL2JY	Limited	Biomarker	[160]
SLC25A14	DTHSNUW	Strong	Altered Expression	[161]
SLC25A27	DT0HW5C	Strong	Altered Expression	[161]

This Disease Is Related to 6 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
ADH5	DEIOH6A	Limited	Biomarker	[162]
HINT1	DEWJATF	Limited	Biomarker	[163]
PGPEP1	DEVDR46	Limited	Biomarker	[164]
GLS	DE3E0VT	Strong	Biomarker	[165]
TGM6	DEUWCVD	Strong	Altered Expression	[166]
GANAB	DEMWKYT	Definitive	Biomarker	[167]

This Disease Is Related to 185 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
ACKR2	OTWYY14H	Limited	Biomarker	[168]
ADGRG3	OTB3XFA1	Limited	Biomarker	[169]
AIMP1	OTTA5C3U	Limited	Biomarker	[170]
ANKRD55	OT62KZII	Limited	Biomarker	[171]
ASPRV1	OT8WVIBW	Limited	Biomarker	[172]
BCAP31	OTKSACR4	Limited	Altered Expression	[173]
BHMT	OTYB6PXZ	Limited	Altered Expression	[30]
BTN2A2	OTUOAJZA	Limited	Biomarker	[174]
C1QTNF6	OT57EPQC	Limited	Biomarker	[175]
CALB2	OTSNMCG9	Limited	Biomarker	[176]
CBLIF	OTNE20WU	Limited	Biomarker	[177]
CCL1	OT23NON8	Limited	Genetic Variation	[178]
CCL25	OTLWJ8CJ	Limited	Biomarker	[179]
CCL4L2	OTDBSXOU	Limited	Genetic Variation	[178]
CCRL2	OT5PX0RX	Limited	Biomarker	[168]
CD99L2	OTQTZFCX	Limited	Biomarker	[180]
CDKN2D	OT2TTZPZ	Limited	Biomarker	[181]
CDR2	OTD3ZJST	Limited	Biomarker	[182]
CH25H	OT9S2BSW	Limited	Genetic Variation	[183]
CIITA	OTRJNZFO	Limited	Biomarker	[184]
COIL	OTP4I4DL	Limited	Biomarker	[185]
CRACR2A	OTJUGSVE	Limited	Biomarker	[186]
CUL9	OTPUCLZT	Limited	Biomarker	[187]
CXXC1	OTO10D1N	Limited	Genetic Variation	[188]
CYBA	OT16N9ZO	Limited	Altered Expression	[21]
DCX	OTISR7K3	Limited	Altered Expression	[176]
DEGS1	OT4WXPKW	Limited	Biomarker	[189]
DNALI1	OTTB3L8N	Limited	Altered Expression	[173]
DUSP14	OTGODFCR	Limited	Biomarker	[190]
EGR2	OTAVQ78J	Limited	Altered Expression	[191]
ELAVL3	OTI2VI8B	Limited	Biomarker	[192]
ENTPD2	OTZ2PKPM	Limited	Biomarker	[193]
FUT7	OTJF6BSN	Limited	Biomarker	[194]
FUT8	OTJJCVG1	Limited	Biomarker	[195]
GOSR1	OTX8TMVU	Limited	Altered Expression	[173]
HECTD3	OTTGP4OK	Limited	Biomarker	[152]
HEPH	OTZ2F15Z	Limited	Altered Expression	[21]
HIP1R	OTIPKEJC	Limited	Biomarker	[196]
HLA-DRB5	OTUX5TWM	Limited	Biomarker	[197]
HPX	OT14T7Q1	Limited	Biomarker	[198]
IL17RC	OTEFOBSS	Limited	Biomarker	[109]
IL27	OTIS3OF8	Limited	Biomarker	[32]
IL27RA	OTSQBAKI	Limited	Biomarker	[199]
IL9R	OTILCLXA	Limited	Altered Expression	[200]
JAM2	OTHVJJRJ	Limited	Biomarker	[201]
LAMTOR1	OTIBJBW9	Limited	Biomarker	[202]
LGALS4	OTKQCG0H	Limited	Biomarker	[203]
LLGL1	OTAIQSXZ	Limited	Biomarker	[204]
MAP1B	OTVXW089	Limited	Biomarker	[205]
MAST2	OT85GLPP	Limited	Altered Expression	[187]
MINK1	OTKB0RA8	Limited	Biomarker	[206]
NCR3	OT20M764	Limited	Biomarker	[207]
NDST1	OT9E10W2	Limited	Altered Expression	[208]
NFE2L1	OT1QHOS2	Limited	Altered Expression	[209]
NRF1	OTOXWNV8	Limited	Altered Expression	[209]
PADI2	OTT40K94	Limited	Biomarker	[210]
PDK4	OTCMHMBZ	Limited	Altered Expression	[211]
PDP2	OTADNMGK	Limited	Altered Expression	[212]
PELI1	OTMLBCLC	Limited	Biomarker	[213]
PGAM5	OT6Q5M0C	Limited	Altered Expression	[214]
PIAS4	OTB7SVMZ	Limited	Genetic Variation	[215]
PIK3AP1	OTMW1B47	Limited	Biomarker	[216]
PNMA1	OTEUG8RL	Limited	Biomarker	[217]
POLR1D	OTOCZQNA	Limited	Altered Expression	[218]
POU2AF1	OTOO6WHL	Limited	Biomarker	[219]
PPP1R11	OTSHYPPW	Limited	Biomarker	[220]
PPP1R15A	OTYG179K	Limited	Biomarker	[221]
PSME3	OTSTC4YY	Limited	Biomarker	[222]
RAB5A	OTFR2KM4	Limited	Altered Expression	[146]
RASA3	OT9C54MN	Limited	Biomarker	[223]
RBM45	OTWTHD77	Limited	Biomarker	[224]
RFX1	OTZUDMPR	Limited	Biomarker	[225]
RRN3	OTKGOZ49	Limited	Altered Expression	[218]
SCNN1A	OTE2KVZV	Limited	Biomarker	[51]
SEMA6B	OT3VVVUO	Limited	Altered Expression	[119]
SLAMF9	OTH1OGZW	Limited	Biomarker	[226]
SNCB	OTELSEK6	Limited	Biomarker	[227]
SOCS2	OTBPNKJQ	Limited	Altered Expression	[228]
ST3GAL4	OTNENJZQ	Limited	Biomarker	[189]
STK24	OTGUHOIL	Limited	Biomarker	[229]
STOML3	OTLQGALK	Limited	Biomarker	[230]
SUMO3	OTTUJQJ1	Limited	Genetic Variation	[215]
SYN2	OTK0DEGH	Limited	Altered Expression	[231]
THYN1	OTMRKMPD	Limited	Biomarker	[232]
TMED5	OT70W1J8	Limited	Altered Expression	[173]
TNFRSF19	OTTVT4MB	Limited	Biomarker	[153]
TRIP4	OTA8OASA	Limited	Biomarker	[160]
AHSA1	OTC7AFHT	moderate	Altered Expression	[233]
ATN1	OTNZFLKY	moderate	Biomarker	[33]
CD1D	OT3ROU4J	moderate	Altered Expression	[234]
GRAP2	OTS5NIZ3	moderate	Altered Expression	[233]
KRT20	OT4RB40L	moderate	Biomarker	[60]
POLDIP2	OT8SZSJ6	moderate	Altered Expression	[233]
PTHLH	OTI1JF13	moderate	Biomarker	[61]
RNF19A	OTKWCV80	moderate	Altered Expression	[233]
AIM2	OT86QUI8	Strong	Biomarker	[235]
AMIGO2	OTPAIT1O	Strong	Biomarker	[236]
ARHGEF2	OTBQTFRT	Strong	Biomarker	[111]
ARMH1	OTTJC0D6	Strong	Biomarker	[111]
ARNT2	OTAQD3YV	Strong	Biomarker	[237]
ATP2B2	OT1NPZ9T	Strong	Biomarker	[238]
AVIL	OTUK67IT	Strong	Biomarker	[239]
BHLHE40	OTITX14U	Strong	Biomarker	[240]
CCDC134	OT70OQQV	Strong	Altered Expression	[241]
CCL26	OT2B7HR9	Strong	Biomarker	[242]
CD200R1	OT65Q9M6	Strong	Altered Expression	[243]
CD226	OT4UG0KB	Strong	Biomarker	[244]
CD48	OT83ZNPP	Strong	Biomarker	[81]
CD93	OT6HZT6H	Strong	Biomarker	[245]
CDCP1	OTD7RRWK	Strong	Biomarker	[246]
CEMIP	OTK80FYN	Strong	Biomarker	[247]
CERS2	OTRAHYYP	Strong	Biomarker	[248]
CERS6	OTOP4GV1	Strong	Biomarker	[249]
CLDN11	OTNN6UTL	Strong	Altered Expression	[250]
CLDN3	OT71MN9S	Strong	Biomarker	[251]
CPT1A	OTI862QH	Strong	Genetic Variation	[252]
CTSZ	OTSCX2LL	Strong	Altered Expression	[253]
DNAJC5	OTCZDXAL	Strong	Biomarker	[254]
DOCK8	OTNQLL21	Strong	Biomarker	[255]
DUSP2	OTH54FMR	Strong	Biomarker	[67]
EBNA1BP2	OTBRVMZH	Strong	Biomarker	[111]
EIF1	OTB4GZ0V	Strong	Biomarker	[138]
EOMES	OTB9VQFA	Strong	Altered Expression	[256]
FABP7	OTRE2H4G	Strong	Biomarker	[257]
FADD	OTV7GFHH	Strong	Biomarker	[258]
FANCC	OTTIDM3P	Strong	Genetic Variation	[259]
FYB1	OT6345CH	Strong	Biomarker	[260]
GPR65	OTCF5O4G	Strong	Altered Expression	[261]
GSDMD	OTH39BKI	Strong	Biomarker	[262]
HAVCR2	OTOL603T	Strong	Biomarker	[263]
HBD	OTRQG4WA	Strong	Altered Expression	[264]
ICAM5	OTDGGAFH	Strong	Biomarker	[114]
IFNA1	OTPMKY0L	Strong	Biomarker	[265]
IL17RA	OTVVI8ER	Strong	Biomarker	[266]
IRGM	OTKD3O5Z	Strong	Biomarker	[267]
ISG20	OTCWRJJW	Strong	Biomarker	[268]
ITGAX	OTOGIMHE	Strong	Altered Expression	[20]
KDM6A	OTZM3MJJ	Strong	Biomarker	[269]
KLK10	OTD573EL	Strong	Biomarker	[116]
LGALS8	OT71LJ8T	Strong	Biomarker	[270]
LILRA1	OTZ4NA7Q	Strong	Biomarker	[271]
LRCH1	OT0RCL85	Strong	Biomarker	[255]
MAK16	OTD546E5	Strong	Biomarker	[105]
MAVS	OTTQ0J64	Strong	Biomarker	[129]
MCF2L2	OTOGFMIH	Strong	Biomarker	[272]
MZB1	OT071TET	Strong	Biomarker	[67]
NPAS4	OTA3HH6W	Strong	Altered Expression	[237]
OCLN	OTSUTVWL	Strong	Biomarker	[273]
OLIG1	OTIMFI31	Strong	Biomarker	[274]
OLIG2	OTMCN6D3	Strong	Biomarker	[275]
OMP	OT7JH0DY	Strong	Biomarker	[230]
OTUB1	OT8WWM9O	Strong	Biomarker	[276]
PANX1	OTXPEDOK	Strong	Biomarker	[277]
PCBP1	OTHN0TD7	Strong	Biomarker	[278]
PIMREG	OTKC8T3E	Strong	Biomarker	[279]
PNO1	OT010GIS	Strong	Biomarker	[105]
PRDX3	OTLB2WEU	Strong	Altered Expression	[161]
PRSS16	OTVCZ5V1	Strong	Biomarker	[280]
PSMD7	OT7PZZ4K	Strong	Biomarker	[111]
PSMG1	OTZ5I6UM	Strong	Biomarker	[67]
RAB32	OTTR4H7S	Strong	Altered Expression	[281]
RABEPK	OTCZSREH	Strong	Biomarker	[111]
RAG1	OTV131E4	Strong	Biomarker	[282]
RASD1	OT2BAJHK	Strong	Genetic Variation	[283]
RBMS3	OTFSC9MR	Strong	Biomarker	[105]
RGCC	OTYJMLWM	Strong	Biomarker	[284]
RMDN1	OTE1NB6U	Strong	Biomarker	[177]
RMDN2	OTK5WSFI	Strong	Biomarker	[177]
RMDN3	OTKO7AUM	Strong	Biomarker	[177]
SEMA7A	OT0ZJK64	Strong	Biomarker	[285]
SIGLEC1	OTNWSQA9	Strong	Altered Expression	[286]
SRRM2	OTSIMMC9	Strong	Biomarker	[105]
SUGP1	OT7W0EB8	Strong	Biomarker	[105]
SYBU	OT3FQV7N	Strong	Biomarker	[177]
SYN1	OTMNPWC1	Strong	Biomarker	[287]
TAGAP	OTHJNNO2	Strong	Biomarker	[288]
TBCA	OTCCWMGK	Strong	Biomarker	[289]
TOB1	OTNW949D	Strong	Biomarker	[290]
TSC22D3	OT03UM03	Strong	Biomarker	[291]
TSPAN32	OTSXW7EW	Strong	Altered Expression	[292]
CLDN5	OTUX60YO	Definitive	Biomarker	[293]
MSC	OTBRPZL5	Definitive	Biomarker	[294]
MYDGF	OT9HRPL6	Definitive	Biomarker	[32]
PLP1	OT8CM9CX	Definitive	Biomarker	[295]
RPS19	OTBKGP48	Definitive	Biomarker	[296]

References

• [1] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
• [2] A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation.J Neuroimmune Pharmacol. 2018 Jun;13(2):265-276. doi: 10.1007/s11481-018-9783-8. Epub 2018 Mar 17.
• [3] Dexmedetomidine, an Alpha 2a Adrenergic Receptor Agonist, Mitigates Experimental Autoimmune Encephalomyelitis by Desensitization of CXCR7 in Microglia.Biochemistry. 2018 Jul 17;57(28):4197-4205. doi: 10.1021/acs.biochem.8b00430. Epub 2018 Jun 26.
• [4] Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.J Neuroinflammation. 2018 May 1;15(1):128. doi: 10.1186/s12974-018-1152-2.
• [5] Activating 7 nicotinic acetylcholine receptor inhibits NLRP3 inflammasome through regulation of -arrestin-1.CNS Neurosci Ther. 2017 Nov;23(11):875-884. doi: 10.1111/cns.12758. Epub 2017 Sep 21.
• [6] Deficiency of -Arrestin 2 in Dendritic Cells Contributes to Autoimmune Diseases.J Immunol. 2019 Jan 15;202(2):407-420. doi: 10.4049/jimmunol.1800261. Epub 2018 Dec 12.
• [7] The Alzheimer's Disease-Associated Protein BACE1 Modulates T Cell Activation and Th17 Function.J Immunol. 2019 Aug 1;203(3):665-675. doi: 10.4049/jimmunol.1800363. Epub 2019 Jun 17.
• [8] Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.J Immunol. 2004 Oct 1;173(7):4708-14. doi: 10.4049/jimmunol.173.7.4708.
• [9] RON-regulated innate immunity is protective in an animal model of multiple sclerosis.Ann Neurol. 2005 Jun;57(6):883-95. doi: 10.1002/ana.20502.
• [10] Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis.Nat Genet. 2010 Jun;42(6):495-7. doi: 10.1038/ng.584. Epub 2010 May 9.
• [11] Cellular FLIP (long isoform) overexpression in T cells drives Th2 effector responses and promotes immunoregulation in experimental autoimmune encephalomyelitis.J Immunol. 2004 Dec 1;173(11):6619-26. doi: 10.4049/jimmunol.173.11.6619.
• [12] The change of PD1, PDL1 in experimental autoimmune encephalomyelitis treated by 1,25(OH)(2)D(3).J Neuroimmunol. 2020 Jan 15;338:577079. doi: 10.1016/j.jneuroim.2019.577079. Epub 2019 Oct 31.
• [13] A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.J Neuroimmunol. 2019 Jul 15;332:8-15. doi: 10.1016/j.jneuroim.2019.03.013. Epub 2019 Mar 21.
• [14] Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells.Front Immunol. 2019 Jun 25;10:1442. doi: 10.3389/fimmu.2019.01442. eCollection 2019.
• [15] Inhibition of Cdk8/Cdk19 Activity Promotes Treg Cell Differentiation and Suppresses Autoimmune Diseases.Front Immunol. 2019 Aug 20;10:1988. doi: 10.3389/fimmu.2019.01988. eCollection 2019.
• [16] Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages.Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6202-E6211. doi: 10.1073/pnas.1705491114. Epub 2017 Jul 10.
• [17] Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10145-50. doi: 10.1073/pnas.1523869113. Epub 2016 Aug 23.
• [18] DGAT1 inhibits retinol-dependent regulatory T cell formation and mediates autoimmune encephalomyelitis.Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3126-3135. doi: 10.1073/pnas.1817669116. Epub 2019 Feb 4.
• [19] Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis.Front Immunol. 2018 Mar 21;9:571. doi: 10.3389/fimmu.2018.00571. eCollection 2018.
• [20] C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance.Front Immunol. 2018 Mar 5;9:372. doi: 10.3389/fimmu.2018.00372. eCollection 2018.
• [21] Oxidative Injury and Iron Redistribution Are Pathological Hallmarks of Marmoset Experimental Autoimmune Encephalomyelitis.J Neuropathol Exp Neurol. 2017 Jun 1;76(6):467-478. doi: 10.1093/jnen/nlx034.
• [22] A role for galanin in human and experimental inflammatory demyelination.Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15466-71. doi: 10.1073/pnas.0903360106. Epub 2009 Aug 26.
• [23] The kinase GLK controls autoimmunity and NF-B signaling by activating the kinase PKC- in T cells.Nat Immunol. 2011 Oct 9;12(11):1113-8. doi: 10.1038/ni.2121.
• [24] Metabolic control of T(H)17 and induced T(reg) cell balance by an epigenetic mechanism.Nature. 2017 Aug 10;548(7666):228-233. doi: 10.1038/nature23475. Epub 2017 Aug 2.
• [25] Imaging fibrosis in inflammatory diseases: targeting the exposed extracellular matrix.Theranostics. 2019 Apr 13;9(10):2868-2881. doi: 10.7150/thno.28892. eCollection 2019.
• [26] Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination.Glia. 2018 May;66(5):1118-1130. doi: 10.1002/glia.23305. Epub 2018 Feb 9.
• [27] Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice.J Clin Invest. 2007 Nov;117(11):3507-18. doi: 10.1172/JCI32792.
• [28] Histamine H?receptor signaling environment interactions determine susceptibility to experimental allergic encephalomyelitis.FASEB J. 2014 Apr;28(4):1898-909. doi: 10.1096/fj.13-239939. Epub 2013 Dec 26.
• [29] Histamine H(3) receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility.PLoS One. 2013 Jul 22;8(7):e62743. doi: 10.1371/journal.pone.0062743. Print 2013.
• [30] 1,25-Dihydroxyvitamin D(3) increases the methionine cycle, CD4(+) T cell DNA methylation and Helios(+)Foxp3(+) T regulatory cells to reverse autoimmune neurodegenerative disease.J Neuroimmunol. 2018 Nov 15;324:100-114. doi: 10.1016/j.jneuroim.2018.09.008. Epub 2018 Sep 21.
• [31] IL-11 regulates autoimmune demyelination.J Immunol. 2009 Oct 1;183(7):4229-40. doi: 10.4049/jimmunol.0900622. Epub 2009 Sep 4.
• [32] Cutting Edge: IL-27 Attenuates Autoimmune Neuroinflammation via Regulatory T Cell/Lag3-Dependent but IL-10-Independent Mechanisms In Vivo.J Immunol. 2019 Mar 15;202(6):1680-1685. doi: 10.4049/jimmunol.1800898. Epub 2019 Jan 30.
• [33] ILDR2-Fc Is a Novel Regulator of Immune Homeostasis and Inducer of Antigen-Specific Immune Tolerance.J Immunol. 2018 Mar 15;200(6):2013-2024. doi: 10.4049/jimmunol.1700326. Epub 2018 Feb 5.
• [34] Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE).J Autoimmun. 2019 Aug;102:77-88. doi: 10.1016/j.jaut.2019.04.020. Epub 2019 Apr 26.
• [35] Altered neuronal expression of TASK1 and TASK3 potassium channels in rodent and human autoimmune CNS inflammation.Neurosci Lett. 2008 Dec 3;446(2-3):133-8. doi: 10.1016/j.neulet.2008.09.038.
• [36] Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis.J Ethnopharmacol. 2018 May 10;217:36-48. doi: 10.1016/j.jep.2018.02.014. Epub 2018 Feb 8.
• [37] Targeting DEC-205(-)DCIR2(+) dendritic cells promotes immunological tolerance in proteolipid protein-induced experimental autoimmune encephalomyelitis.Mol Med. 2018 May 3;24(1):17. doi: 10.1186/s10020-018-0017-6.
• [38] NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-B pathway after intracerebral hemorrhage in mice.J Neuroinflammation. 2019 Oct 28;16(1):192. doi: 10.1186/s12974-019-1591-4.
• [39] Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity.Immunity. 2011 Jan 28;34(1):75-84. doi: 10.1016/j.immuni.2010.12.015. Epub 2011 Jan 13.
• [40] Purinergic receptors in multiple sclerosis pathogenesis.Brain Res Bull. 2019 Sep;151:38-45. doi: 10.1016/j.brainresbull.2018.11.018. Epub 2018 Nov 27.
• [41] A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice.J Chem Neuroanat. 2017 Mar;80:27-36. doi: 10.1016/j.jchemneu.2016.12.001. Epub 2016 Dec 19.
• [42] Exposure to PM(2.5) causes genetic changes in fetal rat cerebral cortex and hippocampus.Environ Toxicol. 2017 Apr;32(4):1412-1425. doi: 10.1002/tox.22335. Epub 2016 Aug 19.
• [43] Cyclophilin inhibitor NIM811 ameliorates experimental allergic encephalomyelitis.J Neuroimmunol. 2017 Oct 15;311:40-48. doi: 10.1016/j.jneuroim.2017.07.016. Epub 2017 Aug 2.
• [44] Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase C (PKC) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis.ACS Med Chem Lett. 2019 Jun 27;10(8):1134-1139. doi: 10.1021/acsmedchemlett.9b00134. eCollection 2019 Aug 8.
• [45] RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis.Nat Med. 2011 Apr;17(4):488-94. doi: 10.1038/nm.2321. Epub 2011 Mar 20.
• [46] Autoimmune animal models in the analysis of the CD47-SIRP signaling pathway.Methods. 2014 Jan 15;65(2):254-9. doi: 10.1016/j.ymeth.2013.09.016. Epub 2013 Oct 1.
• [47] NTB-A, a new activating receptor in T cells that regulates autoimmune disease.J Biol Chem. 2004 Apr 30;279(18):18662-9. doi: 10.1074/jbc.M312313200. Epub 2004 Feb 26.
• [48] Cholinergic imbalance in lumbar spinal cord of a rat model of multiple sclerosis.J Neuroimmunol. 2018 May 15;318:29-35. doi: 10.1016/j.jneuroim.2018.01.016. Epub 2018 Feb 12.
• [49] Gamma-aminobutyric acid transporter 1 negatively regulates T cell-mediated immune responses and ameliorates autoimmune inflammation in the CNS.J Immunol. 2008 Dec 15;181(12):8226-36. doi: 10.4049/jimmunol.181.12.8226.
• [50] Enhanced GABAergic Tonic Inhibition Reduces Intrinsic Excitability of Hippocampal CA1 Pyramidal Cells in Experimental Autoimmune Encephalomyelitis.Neuroscience. 2018 Dec 15;395:89-100. doi: 10.1016/j.neuroscience.2018.11.003. Epub 2018 Nov 14.
• [51] Progression of experimental autoimmune encephalomyelitis is associated with up-regulation of major sodium transporters in the mouse kidney cortex under a normal salt diet.Cell Immunol. 2017 Jul;317:18-25. doi: 10.1016/j.cellimm.2017.04.006. Epub 2017 Apr 18.
• [52] IFN- regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.Mol Immunol. 2018 Jan;93:20-30. doi: 10.1016/j.molimm.2017.11.002. Epub 2017 Nov 8.
• [53] Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.Nat Commun. 2016 Oct 11;7:13048. doi: 10.1038/ncomms13048.
• [54] B cell activating factor (BAFF) selects IL-10(-)B cells over IL-10(+)B cells during inflammatory responses.Mol Immunol. 2017 May;85:18-26. doi: 10.1016/j.molimm.2017.02.002. Epub 2017 Feb 12.
• [55] VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases.Glia. 2018 Dec;66(12):2645-2658. doi: 10.1002/glia.23517. Epub 2018 Oct 11.
• [56] Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.Brain. 2019 Apr 1;142(4):916-931. doi: 10.1093/brain/awz012.
• [57] CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.Clin Rev Allergy Immunol. 2016 Feb;50(1):70-83. doi: 10.1007/s12016-015-8470-2.
• [58] Small Heat Shock Proteins, Amyloid Fibrils, and Nicotine Stimulate a Common Immune Suppressive Pathway with Implications for Future Therapies.Cold Spring Harb Perspect Med. 2019 Jul 1;9(7):a034223. doi: 10.1101/cshperspect.a034223.
• [59] Effects of intestinal nematode treatment on CD11b activation state in an EAE mouse model of multiple sclerosis.Immunobiology. 2019 Nov;224(6):817-826. doi: 10.1016/j.imbio.2019.08.004. Epub 2019 Aug 13.
• [60] Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.Front Immunol. 2019 Oct 18;10:2437. doi: 10.3389/fimmu.2019.02437. eCollection 2019.
• [61] Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.J Neurosci. 2017 Oct 18;37(42):10185-10199. doi: 10.1523/JNEUROSCI.1378-17.2017. Epub 2017 Sep 20.
• [62] Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.J Vis Exp. 2019 Mar 26;(145). doi: 10.3791/59249.
• [63] Oligodendrocytes modulate the immune-inflammatory response in EAE via TNFR2 signaling.Brain Behav Immun. 2020 Feb;84:132-146. doi: 10.1016/j.bbi.2019.11.017. Epub 2019 Nov 27.
• [64] Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.J Neuroinflammation. 2019 Mar 20;16(1):64. doi: 10.1186/s12974-019-1447-y.
• [65] Sialomucin CD43 regulates T helper type 17 cell intercellular adhesion molecule 1 dependent adhesion, apical migration and transendothelial migration.Immunology. 2019 May;157(1):52-69. doi: 10.1111/imm.13047. Epub 2019 Feb 17.
• [66] DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.Brain. 2014 May;137(Pt 5):1454-69. doi: 10.1093/brain/awu045. Epub 2014 Mar 12.
• [67] PACAP/PAC1 Regulation of Inflammation via Catecholaminergic Neurons in a Model of Multiple Sclerosis.J Mol Neurosci. 2019 Jul;68(3):439-451. doi: 10.1007/s12031-018-1137-8. Epub 2018 Jul 30.
• [68] Isotype-Switched Autoantibodies Are Necessary To Facilitate Central Nervous System Autoimmune Disease in Aicda(-/-) and Ung(-/-) Mice.J Immunol. 2018 Aug 15;201(4):1119-1130. doi: 10.4049/jimmunol.1700729. Epub 2018 Jul 6.
• [69] Early P2X7R-dependent activation of microglia during the asymptomatic phase of autoimmune encephalomyelitis.Inflammopharmacology. 2019 Feb;27(1):129-137. doi: 10.1007/s10787-018-0528-3. Epub 2018 Sep 12.
• [70] Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers.Sci Transl Med. 2019 Nov 13;11(518):eaaw0475. doi: 10.1126/scitranslmed.aaw0475.
• [71] Induction of NTPDase1/CD39 by Reactive Microglia and Macrophages Is Associated With the Functional State During EAE.Front Neurosci. 2019 Apr 26;13:410. doi: 10.3389/fnins.2019.00410. eCollection 2019.
• [72] Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis.Mol Neurobiol. 2019 Dec;56(12):8589-8602. doi: 10.1007/s12035-019-01691-w. Epub 2019 Jul 6.
• [73] Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis.Acta Neuropathol Commun. 2018 May 3;6(1):36. doi: 10.1186/s40478-018-0536-y.
• [74] The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.Int J Mol Sci. 2017 Nov 2;18(11):2306. doi: 10.3390/ijms18112306.
• [75] The modulatory effects of luteolin on cyclic AMP/Ciliary neurotrophic factor signaling pathway in experimentally induced autoimmune encephalomyelitis.IUBMB Life. 2019 Sep;71(9):1401-1408. doi: 10.1002/iub.2099. Epub 2019 Jun 11.
• [76] Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis.Acta Neuropathol. 2017 Jul;134(1):15-34. doi: 10.1007/s00401-017-1706-x. Epub 2017 Apr 6.
• [77] CCR6(+) Th cells in the cerebrospinal fluid of persons with multiple sclerosis are dominated by pathogenic non-classic Th1 cells and GM-CSF-only-secreting Th cells.Brain Behav Immun. 2017 Aug;64:71-79. doi: 10.1016/j.bbi.2017.03.008. Epub 2017 Mar 20.
• [78] Assessment of Mitochondrial Dysfunction in Experimental Autoimmune Encephalomyelitis (EAE) Models of Multiple Sclerosis.Int J Mol Sci. 2019 Oct 9;20(20):4975. doi: 10.3390/ijms20204975.
• [79] Gestational Hypothyroxinemia Affects Its Offspring With a Reduced Suppressive Capacity Impairing the Outcome of the Experimental Autoimmune Encephalomyelitis.Front Immunol. 2018 Jun 6;9:1257. doi: 10.3389/fimmu.2018.01257. eCollection 2018.
• [80] Defects in CD4+ T cell LFA-1 integrin-dependent adhesion and proliferation protect Cd47-/- mice from EAE.J Leukoc Biol. 2017 Feb;101(2):493-505. doi: 10.1189/jlb.3A1215-546RR. Epub 2016 Dec 13.
• [81] Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells.J Immunol. 2016 Oct 15;197(8):3038-3048. doi: 10.4049/jimmunol.1600706. Epub 2016 Aug 31.
• [82] Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation.Front Immunol. 2018 Jan 25;9:50. doi: 10.3389/fimmu.2018.00050. eCollection 2018.
• [83] Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.Sci Rep. 2017 Jun 2;7(1):2707. doi: 10.1038/s41598-017-03027-x.
• [84] Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.Sci Rep. 2019 May 9;9(1):7178. doi: 10.1038/s41598-019-43428-8.
• [85] Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.J Neurochem. 2019 Feb;148(3):413-425. doi: 10.1111/jnc.14581. Epub 2018 Dec 3.
• [86] Cathepsin E in neutrophils contributes to the generation of neuropathic pain in experimental autoimmune encephalomyelitis.Pain. 2019 Sep;160(9):2050-2062. doi: 10.1097/j.pain.0000000000001596.
• [87] Cathepsin H deficiency in mice induces excess Th1 cell activation and early-onset of EAE though impairment of toll-like receptor 3 cascade.Inflamm Res. 2018 May;67(5):371-374. doi: 10.1007/s00011-018-1136-9. Epub 2018 Feb 22.
• [88] Protective effects of CX3CR1 on autoimmune inflammation in a chronic EAE model for MS through modulation of antigen-presenting cell-related molecular MHC-II and its regulators.Neurol Sci. 2019 Apr;40(4):779-791. doi: 10.1007/s10072-019-3721-2. Epub 2019 Jan 23.
• [89] Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation.Front Immunol. 2018 Feb 27;9:382. doi: 10.3389/fimmu.2018.00382. eCollection 2018.
• [90] Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis Optica.J Immunol Res. 2018 Dec 13;2018:9034695. doi: 10.1155/2018/9034695. eCollection 2018.
• [91] Nox2-dependent Neuroinflammation in An EAE Model of Multiple Sclerosis.Transl Neurosci. 2019 Mar 26;10:1-9. doi: 10.1515/tnsci-2019-0001. eCollection 2019.
• [92] Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord.Sci Rep. 2017 Jun 2;7(1):2702. doi: 10.1038/s41598-017-02638-8.
• [93] Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.Brain. 2012 Jun;135(Pt 6):1794-818. doi: 10.1093/brain/aws100. Epub 2012 Apr 28.
• [94] MicroRNA-92a Drives Th1 Responses in the Experimental Autoimmune Encephalomyelitis.Inflammation. 2019 Feb;42(1):235-245. doi: 10.1007/s10753-018-0887-3.
• [95] EGFL7 reduces CNS inflammation in mouse.Nat Commun. 2018 Feb 26;9(1):819. doi: 10.1038/s41467-018-03186-z.
• [96] Bacoside-A inhibits inflammatory cytokines and chemokine in experimental autoimmune encephalomyelitis.Biomed Pharmacother. 2019 Jan;109:1339-1345. doi: 10.1016/j.biopha.2018.10.188. Epub 2018 Nov 9.
• [97] Therapeutic efficacy of multipotent adult progenitor cells versus mesenchymal stem cells in experimental autoimmune encephalomyelitis.Regen Med. 2017 Apr;12(4):377-396. doi: 10.2217/rme-2016-0109. Epub 2017 Jun 16.
• [98] Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack.Mult Scler Relat Disord. 2019 Apr;29:94-99. doi: 10.1016/j.msard.2019.01.036. Epub 2019 Jan 24.
• [99] Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.Glia. 2018 Dec;66(12):2589-2603. doi: 10.1002/glia.23513. Epub 2018 Oct 16.
• [100] Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.Front Immunol. 2018 Nov 7;9:2588. doi: 10.3389/fimmu.2018.02588. eCollection 2018.
• [101] Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models.Arthritis Rheum. 2011 Feb;63(2):455-66. doi: 10.1002/art.30108.
• [102] EBI2 - Sensor for dihydroxycholesterol gradients in neuroinflammation.Biochimie. 2018 Oct;153:52-55. doi: 10.1016/j.biochi.2018.04.014. Epub 2018 Apr 22.
• [103] Glutamate, T cells and multiple sclerosis.J Neural Transm (Vienna). 2017 Jul;124(7):775-798. doi: 10.1007/s00702-016-1661-z. Epub 2017 Feb 24.
• [104] Modulation of neurological deficits and expression of glutamate receptors during experimental autoimmune encephalomyelitis after treatment with selected antagonists of glutamate receptors.Biomed Res Int. 2013;2013:186068. doi: 10.1155/2013/186068. Epub 2013 Jul 8.
• [105] Dysfunctional RNA-binding protein biology and neurodegeneration in experimental autoimmune encephalomyelitis in female mice.J Neurosci Res. 2020 Apr;98(4):704-717. doi: 10.1002/jnr.24554. Epub 2019 Nov 22.
• [106] Neuronal IFN-beta-induced PI3K/Akt-FoxA1 signalling is essential for generation of FoxA1(+)T(reg) cells.Nat Commun. 2017 Apr 24;8:14709. doi: 10.1038/ncomms14709.
• [107] B cell function impacts the efficacy of IFN- therapy in EAE.J Neuroimmunol. 2020 Jan 15;338:577106. doi: 10.1016/j.jneuroim.2019.577106. Epub 2019 Nov 6.
• [108] Mode of Action of Aspirin in Experimental Autoimmune Encephalomyelitis.DNA Cell Biol. 2019 Jul;38(7):593-596. doi: 10.1089/dna.2019.4814. Epub 2019 May 28.
• [109] IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.J Immunol. 2010 Apr 15;184(8):4307-16. doi: 10.4049/jimmunol.0903614. Epub 2010 Mar 15.
• [110] IL-23 drives differentiation of peripheral 17 T cells from adult bone marrow-derived precursors.EMBO Rep. 2017 Nov;18(11):1957-1967. doi: 10.15252/embr.201744200. Epub 2017 Aug 30.
• [111] Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.Immunol Cell Biol. 2017 Aug;95(7):593-600. doi: 10.1038/icb.2017.11. Epub 2017 Feb 16.
• [112] Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation.Clin Immunol. 2015 Dec;161(2):260-9. doi: 10.1016/j.clim.2015.08.007. Epub 2015 Aug 25.
• [113] Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides.Sci Rep. 2019 Sep 10;9(1):12994. doi: 10.1038/s41598-019-49385-6.
• [114] Neuronal ICAM-5 Plays a Neuroprotective Role in Progressive Neurodegeneration.Front Neurol. 2019 Mar 12;10:205. doi: 10.3389/fneur.2019.00205. eCollection 2019.
• [115] Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis.Glia. 2018 Feb;66(2):359-378. doi: 10.1002/glia.23249. Epub 2017 Oct 31.
• [116] Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.Biol Chem. 2014 Sep;395(9):1063-73. doi: 10.1515/hsz-2014-0141.
• [117] The protective effect of extra-virgin olive oil in the experimental model of multiple sclerosis in the rat.Nutr Neurosci. 2020 Jan;23(1):37-48. doi: 10.1080/1028415X.2018.1469281. Epub 2018 May 5.
• [118] LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.Mol Neurobiol. 2017 Aug;54(6):4365-4378. doi: 10.1007/s12035-016-9994-z. Epub 2016 Jun 25.
• [119] An interferon--resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage.Nat Neurosci. 2016 Dec;19(12):1599-1609. doi: 10.1038/nn.4421. Epub 2016 Nov 7.
• [120] Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis.Neurosci Lett. 2020 Jan 10;715:134599. doi: 10.1016/j.neulet.2019.134599. Epub 2019 Nov 10.
• [121] Delayed Astrogliosis Associated with Reduced M1 Microglia Activation in Matrix Metalloproteinase 12 Knockout Mice during Theiler's Murine Encephalomyelitis.Int J Mol Sci. 2019 Apr 5;20(7):1702. doi: 10.3390/ijms20071702.
• [122] Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.Brain Behav Immun. 2018 Feb;68:44-55. doi: 10.1016/j.bbi.2017.09.015. Epub 2017 Sep 27.
• [123] Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation.Nat Commun. 2015 Oct 5;6:8437. doi: 10.1038/ncomms9437.
• [124] Matrine promotes NT3 expression in CNS cells in experimental autoimmune encephalomyelitis.Neurosci Lett. 2017 May 10;649:100-106. doi: 10.1016/j.neulet.2017.04.005. Epub 2017 Apr 6.
• [125] Netrin-1 and multiple sclerosis: a new biomarker for neuroinflammation?.Eur J Neurol. 2017 Sep;24(9):1108-1115. doi: 10.1111/ene.13340. Epub 2017 Jul 5.
• [126] Necrostatin-1 ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by suppressing apoptosis and necroptosis of oligodendrocyte precursor cells.Exp Ther Med. 2019 Nov;18(5):4113-4119. doi: 10.3892/etm.2019.8005. Epub 2019 Sep 13.
• [127] InCl(3) mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis.Eur J Med Chem. 2019 Jul 15;174:198-215. doi: 10.1016/j.ejmech.2019.04.020. Epub 2019 Apr 16.
• [128] Schlafen-8 is essential for lymphatic endothelial cell activation in experimental autoimmune encephalomyelitis.Int Immunol. 2018 Mar 8;30(2):69-78. doi: 10.1093/intimm/dxx079.
• [129] Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS.Cell. 2019 Dec 12;179(7):1483-1498.e22. doi: 10.1016/j.cell.2019.11.016. Epub 2019 Dec 5.
• [130] NF-B/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms.Front Immunol. 2019 Mar 19;10:524. doi: 10.3389/fimmu.2019.00524. eCollection 2019.
• [131] Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.Metab Brain Dis. 2015 Feb;30(1):57-65. doi: 10.1007/s11011-014-9558-8. Epub 2014 May 9.
• [132] Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity.EMBO Rep. 2018 Dec;19(12):e46512. doi: 10.15252/embr.201846512. Epub 2018 Oct 2.
• [133] Endothelial Microsomal Prostaglandin E Synthetase-1 Upregulates Vascularity and Endothelial Interleukin-1 in Deteriorative Progression of Experimental Autoimmune Encephalomyelitis.Int J Mol Sci. 2018 Nov 19;19(11):3647. doi: 10.3390/ijms19113647.
• [134] T-Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell Differentiation.Immunity. 2018 Nov 20;49(5):873-885.e7. doi: 10.1016/j.immuni.2018.08.022. Epub 2018 Oct 23.
• [135] Absence of system x(c)(-) on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis.J Neuroinflammation. 2017 Jan 13;14(1):9. doi: 10.1186/s12974-016-0787-0.
• [136] Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis.Neurosignals. 2019;27(S1):20-31. doi: 10.33594/000000183.
• [137] Role of Sortilin in Models of Autoimmune Neuroinflammation.J Immunol. 2015 Dec 15;195(12):5762-9. doi: 10.4049/jimmunol.1403156. Epub 2015 Nov 13.
• [138] Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences.J Neuroimmunol. 2018 Sep 15;322:46-56. doi: 10.1016/j.jneuroim.2018.06.009. Epub 2018 Jun 15.
• [139] NDR1 protein kinase promotes IL-17- and TNF--mediated inflammation by competitively binding TRAF3.EMBO Rep. 2017 Apr;18(4):586-602. doi: 10.15252/embr.201642140. Epub 2017 Feb 20.
• [140] The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity.Nat Commun. 2016 Jul 15;7:12073. doi: 10.1038/ncomms12073.
• [141] Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.Sci Rep. 2017 Jan 24;7:41271. doi: 10.1038/srep41271.
• [142] 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo.PLoS One. 2013;8(3):e58808. doi: 10.1371/journal.pone.0058808. Epub 2013 Mar 14.
• [143] The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways.Immunity. 2016 Jun 21;44(6):1271-83. doi: 10.1016/j.immuni.2016.05.013. Epub 2016 Jun 14.
• [144] The ion channel TRPM4 in murine experimental autoimmune encephalomyelitis and in a model of glutamate-induced neuronal degeneration.Mol Brain. 2018 Jul 11;11(1):41. doi: 10.1186/s13041-018-0385-4.
• [145] The cooling compound icilin attenuates autoimmune neuroinflammation through modulation of the T-cell response.FASEB J. 2018 Mar;32(3):1236-1249. doi: 10.1096/fj.201700552R. Epub 2018 Jan 3.
• [146] Ulk1 Governs Nerve Growth Factor/TrkA Signaling by Mediating Rab5 GTPase Activation in Porcine Hemagglutinating Encephalomyelitis Virus-Induced Neurodegenerative Disorders.J Virol. 2018 Jul 31;92(16):e00325-18. doi: 10.1128/JVI.00325-18. Print 2018 Aug 15.
• [147] Microglial control of astrocytes in response to microbial metabolites.Nature. 2018 May;557(7707):724-728. doi: 10.1038/s41586-018-0119-x. Epub 2018 May 16.
• [148] The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels.J Neuroimmunol. 2018 May 15;318:87-96. doi: 10.1016/j.jneuroim.2018.02.012. Epub 2018 Feb 24.
• [149] Strain differences in thymic atrophy in rats immunized for EAE correlate with the clinical outcome of immunization.PLoS One. 2018 Aug 7;13(8):e0201848. doi: 10.1371/journal.pone.0201848. eCollection 2018.
• [150] Analysis of Long Noncoding RNA and mRNA Expression Profiles in IL-9-Activated Astrocytes and EAE Mice.Cell Physiol Biochem. 2018;45(5):1986-1998. doi: 10.1159/000487975. Epub 2018 Mar 2.
• [151] Multiple Sclerosis Gene Therapy with Recombinant Viral Vectors: Overexpression of IL-4, Leukemia Inhibitory Factor, and IL-10 in Wharton's Jelly Stem Cells Used in EAE Mice Model.Cell J. 2017 Oct;19(3):361-374. doi: 10.22074/cellj.2017.4497. Epub 2017 Aug 19.
• [152] Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation.Nat Commun. 2019 Feb 11;10(1):701. doi: 10.1038/s41467-019-08605-3.
• [153] p75NTR and TROY: Uncharted Roles of Nogo Receptor Complex in Experimental Autoimmune Encephalomyelitis.Mol Neurobiol. 2018 Aug;55(8):6329-6336. doi: 10.1007/s12035-017-0841-7. Epub 2018 Jan 2.
• [154] Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation.J Autoimmun. 2019 Dec;105:102290. doi: 10.1016/j.jaut.2019.06.001. Epub 2019 Jun 12.
• [155] Celastrol suppresses experimental autoimmune encephalomyelitis via MAPK/SGK1-regulated mediators of autoimmune pathology.Inflamm Res. 2019 Apr;68(4):285-296. doi: 10.1007/s00011-019-01219-x. Epub 2019 Feb 28.
• [156] Resveratrol (3, 5, 4'-Trihydroxy-trans-Stilbene) Attenuates a Mouse Model of Multiple Sclerosis by Altering the miR-124/Sphingosine Kinase 1 Axis in Encephalitogenic T Cells in the Brain.J Neuroimmune Pharmacol. 2019 Sep;14(3):462-477. doi: 10.1007/s11481-019-09842-5. Epub 2019 Apr 2.
• [157] Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis.Front Immunol. 2018 Mar 2;9:281. doi: 10.3389/fimmu.2018.00281. eCollection 2018.
• [158] Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS.Nat Med. 2013 Sep;19(9):1161-5. doi: 10.1038/nm.3303. Epub 2013 Aug 11.
• [159] Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.Glia. 2012 Jul;60(7):1145-59. doi: 10.1002/glia.22342. Epub 2012 Apr 12.
• [160] Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response.PLoS One. 2017 Apr 7;12(4):e0175575. doi: 10.1371/journal.pone.0175575. eCollection 2017.
• [161] Up-regulation of PGC-1 in neurons protects against experimental autoimmune encephalomyelitis.FASEB J. 2019 Dec;33(12):14811-14824. doi: 10.1096/fj.201901149RR. Epub 2019 Nov 13.
• [162] S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.Free Radic Biol Med. 2018 Jun;121:57-68. doi: 10.1016/j.freeradbiomed.2018.04.558. Epub 2018 Apr 22.
• [163] NK Cell Induced T Cell Anergy Depends on GRAIL Expression.Cells. 2019 Jul 29;8(8):790. doi: 10.3390/cells8080790.
• [164] Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis.Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21807-12. doi: 10.1073/pnas.0906891106. Epub 2009 Dec 7.
• [165] Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.Arthritis Rheumatol. 2019 Nov;71(11):1869-1878. doi: 10.1002/art.41019. Epub 2019 Sep 27.
• [166] Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.Mult Scler. 2017 Nov;23(13):1707-1715. doi: 10.1177/1352458516684022. Epub 2016 Dec 22.
• [167] Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis.Brain. 2009 May;132(Pt 5):1221-35. doi: 10.1093/brain/awp002. Epub 2009 Feb 13.
• [168] Role of Atypical Chemokine Receptors in Microglial Activation and Polarization.Front Aging Neurosci. 2017 May 26;9:148. doi: 10.3389/fnagi.2017.00148. eCollection 2017.
• [169] Gpr97/Adgrg3 ameliorates experimental autoimmune encephalomyelitis by regulating cytokine expression.Acta Biochim Biophys Sin (Shanghai). 2018 Jul 1;50(7):666-675. doi: 10.1093/abbs/gmy060.
• [170] Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells.Glia. 1997 Aug;20(4):365-72. doi: 10.1002/(sici)1098-1136(199708)20:4<365::aid-glia8>3.0.co;2-4.
• [171] Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.J Immunol. 2016 Jun 1;196(11):4553-65. doi: 10.4049/jimmunol.1501205. Epub 2016 May 4.
• [172] ICAM1+ neutrophils promote chronic inflammation via ASPRV1 in B cell-dependent autoimmune encephalomyelitis.JCI Insight. 2017 Dec 7;2(23):e96882. doi: 10.1172/jci.insight.96882.
• [173] IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells.J Immunol. 2009 May 1;182(9):5748-56. doi: 10.4049/jimmunol.0801162.
• [174] Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes.J Exp Med. 2016 Feb 8;213(2):177-87. doi: 10.1084/jem.20150435. Epub 2016 Jan 25.
• [175] CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis.Nat Commun. 2015 Sep 25;6:8483. doi: 10.1038/ncomms9483.
• [176] Long-term effects of autoimmune CNS inflammation on adult hippocampal neurogenesis.J Neurosci Res. 2017 Jul;95(7):1446-1458. doi: 10.1002/jnr.23982. Epub 2016 Oct 26.
• [177] Autophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells.Autophagy. 2020 Jan;16(1):28-37. doi: 10.1080/15548627.2019.1630223. Epub 2019 Jun 18.
• [178] Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis.J Immunol. 1999 Aug 15;163(4):2262-6.
• [179] Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis.J Neuroimmune Pharmacol. 2019 Sep;14(3):493-502. doi: 10.1007/s11481-019-09854-1. Epub 2019 May 8.
• [180] CD99L2 deficiency inhibits leukocyte entry into the central nervous system and ameliorates neuroinflammation.J Leukoc Biol. 2018 Oct;104(4):787-797. doi: 10.1002/JLB.1A0617-228R. Epub 2018 May 23.
• [181] Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells.Clin Exp Immunol. 2014 May;176(2):180-9. doi: 10.1111/cei.12266.
• [182] Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides.J Immunol. 1994 Mar 1;152(5):2520-9.
• [183] Oxysterols regulate encephalitogenic CD4(+) T cell trafficking during central nervous system autoimmunity.J Autoimmun. 2015 Jan;56:45-55. doi: 10.1016/j.jaut.2014.10.001. Epub 2014 Nov 10.
• [184] Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases.Immunology. 2017 Apr;150(4):408-417. doi: 10.1111/imm.12692. Epub 2016 Dec 22.
• [185] Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression.Autoimmunity. 2004 Sep-Nov;37(6-7):465-71. doi: 10.1080/08916930400001859.
• [186] CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses.J Immunol. 2018 Aug 15;201(4):1174-1185. doi: 10.4049/jimmunol.1800659. Epub 2018 Jul 9.
• [187] Novel genes in brain tissues of EAE-induced normal and obese mice: Upregulation of metal ion-binding protein genes in obese-EAE mice.Neuroscience. 2017 Feb 20;343:322-336. doi: 10.1016/j.neuroscience.2016.12.002. Epub 2016 Dec 10.
• [188] Epigenetic initiation of the T(H)17 differentiation program is promoted by Cxxc finger protein 1.Sci Adv. 2019 Oct 9;5(10):eaax1608. doi: 10.1126/sciadv.aax1608. eCollection 2019 Oct.
• [189] The roles of Galectin-3 in autoimmunity and tumor progression.Immunol Res. 2012 Apr;52(1-2):100-10. doi: 10.1007/s12026-012-8286-6.
• [190] Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation.J Immunol. 2014 Feb 15;192(4):1547-57. doi: 10.4049/jimmunol.1300989. Epub 2014 Jan 8.
• [191] Early growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating Batf.J Immunol. 2013 Jan 1;190(1):58-65. doi: 10.4049/jimmunol.1200868. Epub 2012 Nov 30.
• [192] Antibody recognition and RNA binding of a neuronal nuclear autoantigen associated with paraneoplastic neurological syndromes and small cell lung carcinoma.J Neuroimmunol. 1999 Jan 1;93(1-2):37-44. doi: 10.1016/s0165-5728(98)00184-2.
• [193] Down-regulation of NTPDase2 and ADP-sensitive P2 Purinoceptors Correlate with Severity of Symptoms during Experimental Autoimmune Encephalomyelitis.Front Cell Neurosci. 2017 Oct 30;11:333. doi: 10.3389/fncel.2017.00333. eCollection 2017.
• [194] Efficient recruitment of lymphocytes in inflamed brain venules requires expression of cutaneous lymphocyte antigen and fucosyltransferase-VII.J Immunol. 2005 May 1;174(9):5805-13. doi: 10.4049/jimmunol.174.9.5805.
• [195] Core Fucosylation of the T Cell Receptor Is Required for T Cell Activation.Front Immunol. 2018 Jan 29;9:78. doi: 10.3389/fimmu.2018.00078. eCollection 2018.
• [196] Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis.Behav Brain Res. 2017 Jan 15;317:95-108. doi: 10.1016/j.bbr.2016.09.034. Epub 2016 Sep 14.
• [197] Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.J Immunol. 2008 Oct 15;181(8):5473-80. doi: 10.4049/jimmunol.181.8.5473.
• [198] Acute-phase protein hemopexin is a negative regulator of Th17 response and experimental autoimmune encephalomyelitis development.J Immunol. 2013 Dec 1;191(11):5451-9. doi: 10.4049/jimmunol.1203076. Epub 2013 Oct 23.
• [199] Induction of Peripheral Tolerance in Ongoing Autoimmune Inflammation Requires Interleukin 27 Signaling in Dendritic Cells.Front Immunol. 2017 Oct 27;8:1392. doi: 10.3389/fimmu.2017.01392. eCollection 2017.
• [200] Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis.Chin Med J (Engl). 2017 Apr 20;130(8):964-971. doi: 10.4103/0366-6999.204110.
• [201] Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.Brain Behav Immun. 2018 Oct;73:3-20. doi: 10.1016/j.bbi.2018.06.014. Epub 2018 Jun 18.
• [202] Lamtor1 Is Critically Required for CD4(+) T Cell Proliferation and Regulatory T Cell Suppressive Function.J Immunol. 2017 Sep 15;199(6):2008-2019. doi: 10.4049/jimmunol.1700157. Epub 2017 Aug 2.
• [203] Galectin-4, a Negative Regulator of Oligodendrocyte Differentiation, Is Persistently Present in Axons and Microglia/Macrophages in Multiple Sclerosis Lesions.J Neuropathol Exp Neurol. 2018 Nov 1;77(11):1024-1038. doi: 10.1093/jnen/nly081.
• [204] Macrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammation.J Neuroinflammation. 2019 Jun 27;16(1):130. doi: 10.1186/s12974-019-1522-4.
• [205] Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.J Neuropathol Exp Neurol. 2012 May;71(5):422-33. doi: 10.1097/NEN.0b013e3182540d2e.
• [206] Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1.J Exp Med. 2017 May 1;214(5):1453-1469. doi: 10.1084/jem.20161120. Epub 2017 Apr 11.
• [207] The Major Histocompatibility Complex Class III Haplotype Ltab-Ncr3 Regulates Adjuvant-Induced but Not Antigen-Induced Autoimmunity.Am J Pathol. 2017 May;187(5):987-998. doi: 10.1016/j.ajpath.2016.12.022. Epub 2017 Mar 18.
• [208] Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis.Acta Neuropathol Commun. 2018 Jan 4;6(1):4. doi: 10.1186/s40478-017-0506-9.
• [209] Decreased levels of constitutive proteasomes in experimental autoimmune encephalomyelitis may be caused by a combination of subunit displacement and reduced Nfe2l1 expression.J Neurochem. 2020 Mar;152(5):585-601. doi: 10.1111/jnc.14912. Epub 2019 Dec 2.
• [210] Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice.J Comp Neurol. 2006 Sep 10;498(2):217-26. doi: 10.1002/cne.21055.
• [211] Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis.Front Pharmacol. 2019 Feb 28;10:147. doi: 10.3389/fphar.2019.00147. eCollection 2019.
• [212] Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation.Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9288-9293. doi: 10.1073/pnas.1805717115. Epub 2018 Aug 27.
• [213] Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection.J Clin Invest. 2018 Nov 1;128(11):4980-4991. doi: 10.1172/JCI99902. Epub 2018 Sep 24.
• [214] Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia.Biochem Biophys Res Commun. 2018 Feb 26;497(1):80-86. doi: 10.1016/j.bbrc.2018.02.024. Epub 2018 Feb 3.
• [215] Sumoylation of RORt regulates T(H)17 differentiation and thymocyte development.Nat Commun. 2018 Nov 19;9(1):4870. doi: 10.1038/s41467-018-07203-z.
• [216] BCAP links IL-1R to the PI3K-mTOR pathway and regulates pathogenic Th17 cell differentiation.J Exp Med. 2018 Sep 3;215(9):2413-2428. doi: 10.1084/jem.20171810. Epub 2018 Aug 9.
• [217] Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat.Brain. 2004 Aug;127(Pt 8):1822-30. doi: 10.1093/brain/awh205. Epub 2004 Jun 16.
• [218] Experimental Autoimmune Encephalomyelitis Ameliorated by Passive Transfer of Polymerase 1-Silenced MOG35-55 Lymphatic Node Cells: Verification of a Novel Therapeutic Approach in Multiple Sclerosis.Neuromolecular Med. 2017 Sep;19(2-3):406-412. doi: 10.1007/s12017-017-8456-8. Epub 2017 Jul 28.
• [219] Bob1 enhances RORt-mediated IL-17A expression in Th17cells through interaction with RORt.Biochem Biophys Res Commun. 2019 Jul 5;514(4):1167-1171. doi: 10.1016/j.bbrc.2019.05.057. Epub 2019 May 15.
• [220] Defective autophagy is associated with neuronal injury in a mouse model of multiple sclerosis.Bosn J Basic Med Sci. 2017 May 20;17(2):95-103. doi: 10.17305/bjbms.2017.1696.
• [221] Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis.Brain. 2019 Feb 1;142(2):344-361. doi: 10.1093/brain/awy322.
• [222] REG controls Th17 cell differentiation and autoimmune inflammation by regulating dendritic cells.Cell Mol Immunol. 2020 Nov;17(11):1136-1147. doi: 10.1038/s41423-019-0287-0. Epub 2019 Sep 11.
• [223] RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs.Immunity. 2018 Nov 20;49(5):886-898.e5. doi: 10.1016/j.immuni.2018.09.004. Epub 2018 Nov 13.
• [224] Absence of IFN- increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the central nervous system.J Immunol. 2014 Nov 15;193(10):4859-70. doi: 10.4049/jimmunol.1302008. Epub 2014 Oct 22.
• [225] IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation.Nat Commun. 2018 Feb 8;9(1):583. doi: 10.1038/s41467-018-02890-0.
• [226] SLAMF9 regulates pDC homeostasis and function in health and disease.Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16489-16496. doi: 10.1073/pnas.1900079116. Epub 2019 Jul 25.
• [227] Autoimmune spread to myelin is associated with experimental autoimmune encephalomyelitis induced by a neuronal protein, beta-synuclein.J Neuroimmunol. 2009 Mar 31;208(1-2):19-29. doi: 10.1016/j.jneuroim.2008.12.009. Epub 2009 Feb 1.
• [228] Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.Nat Med. 2016 Jun;22(6):586-97. doi: 10.1038/nm.4106. Epub 2016 May 9.
• [229] Protein Kinase Serine/Threonine Kinase 24 Positively Regulates Interleukin 17-Induced Inflammation by Promoting IKK Complex Activation.Front Immunol. 2018 Apr 30;9:921. doi: 10.3389/fimmu.2018.00921. eCollection 2018.
• [230] Gene Expression Profile of Olfactory Transduction Signaling in an Animal Model of Human Multiple Sclerosis.Exp Neurobiol. 2019 Feb;28(1):74-84. doi: 10.5607/en.2019.28.1.74. Epub 2019 Feb 28.
• [231] Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis.Front Immunol. 2017 Jul 17;8:812. doi: 10.3389/fimmu.2017.00812. eCollection 2017.
• [232] Thy28 protects against anti-CD3-mediated thymic cell death in vivo.Apoptosis. 2015 Apr;20(4):444-54. doi: 10.1007/s10495-014-1082-0.
• [233] Graphene quantum dots inhibit T cell-mediated neuroinflammation in rats.Neuropharmacology. 2019 Mar 1;146:95-108. doi: 10.1016/j.neuropharm.2018.11.030. Epub 2018 Nov 22.
• [234] Abrogation of Endogenous Glycolipid Antigen Presentation on Myelin-Laden Macrophages by D-Sphingosine Ameliorates the Pathogenesis of Experimental Autoimmune Encephalomyelitis.Front Immunol. 2019 Mar 19;10:404. doi: 10.3389/fimmu.2019.00404. eCollection 2019.
• [235] Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review.Mediators Inflamm. 2018 Apr 17;2018:1549549. doi: 10.1155/2018/1549549. eCollection 2018.
• [236] AMIGO2 modulates T cell functions and its deficiency in mice ameliorates experimental autoimmune encephalomyelitis.Brain Behav Immun. 2017 May;62:110-123. doi: 10.1016/j.bbi.2017.01.009. Epub 2017 Feb 1.
• [237] Expression of the neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple sclerosis.J Neuroinflammation. 2018 Sep 19;15(1):270. doi: 10.1186/s12974-018-1290-6.
• [238] Pathological pain processing in mouse models of multiple sclerosis and spinal cord injury: contribution of plasma membrane calcium ATPase 2 (PMCA2).J Neuroinflammation. 2019 Nov 8;16(1):207. doi: 10.1186/s12974-019-1585-2.
• [239] Involvement of advillin in somatosensory neuron subtype-specific axon regeneration and neuropathic pain.Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8557-E8566. doi: 10.1073/pnas.1716470115. Epub 2018 Aug 20.
• [240] Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation.Nat Commun. 2014 Apr 3;5:3551. doi: 10.1038/ncomms4551.
• [241] CCDC134 ameliorated experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.Brain Behav Immun. 2018 Jul;71:158-168. doi: 10.1016/j.bbi.2018.03.015. Epub 2018 Mar 14.
• [242] CCL26 and CCR3 are associated with the acute inflammatory response in the CNS in experimental autoimmune encephalomyelitis.J Neuroimmunol. 2019 Aug 15;333:576967. doi: 10.1016/j.jneuroim.2019.576967. Epub 2019 May 16.
• [243] Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages.Front Cell Neurosci. 2017 May 4;11:129. doi: 10.3389/fncel.2017.00129. eCollection 2017.
• [244] CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.Oncotarget. 2016 Apr 12;7(15):19251-64. doi: 10.18632/oncotarget.7834.
• [245] CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis.Immunology. 2018 Nov;155(3):346-355. doi: 10.1111/imm.12974. Epub 2018 Jul 11.
• [246] Clinical and experimental evidence for targeting CD6 in immune-based disorders.Autoimmun Rev. 2018 May;17(5):493-503. doi: 10.1016/j.autrev.2017.12.004. Epub 2018 Mar 9.
• [247] KIAA1199 expression and hyaluronan degradation colocalize in multiple sclerosis lesions.Glycobiology. 2018 Dec 1;28(12):958-967. doi: 10.1093/glycob/cwy064.
• [248] Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation into detergent-resistant membranes.Sci Rep. 2019 Jan 24;9(1):747. doi: 10.1038/s41598-018-37342-8.
• [249] Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.Immunol Cell Biol. 2015 Oct;93(9):825-36. doi: 10.1038/icb.2015.47. Epub 2015 Apr 2.
• [250] Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis.Mol Neurobiol. 2019 Mar;56(3):2039-2056. doi: 10.1007/s12035-018-1207-5. Epub 2018 Jul 8.
• [251] Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation.Acta Neuropathol. 2014 Aug;128(2):267-77. doi: 10.1007/s00401-013-1227-1. Epub 2013 Dec 20.
• [252] CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis.Sci Rep. 2019 Sep 16;9(1):13299. doi: 10.1038/s41598-019-49868-6.
• [253] A role for cathepsin Z in neuroinflammation provides mechanistic support for an epigenetic risk factor in multiple sclerosis.J Neuroinflammation. 2017 May 10;14(1):103. doi: 10.1186/s12974-017-0874-x.
• [254] Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: beneficial effects in experimental autoimmune encephalomyelitis.BMC Complement Altern Med. 2013 Jun 28;13:149. doi: 10.1186/1472-6882-13-149.
• [255] LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis.J Exp Med. 2017 Jan;214(1):209-226. doi: 10.1084/jem.20160068.
• [256] Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammation.Neurochem Int. 2019 Nov;130:104348. doi: 10.1016/j.neuint.2018.11.023. Epub 2018 Dec 1.
• [257] The role of fatty acid binding protein 7 in spinal cord astrocytes in a mouse model of experimental autoimmune encephalomyelitis.Neuroscience. 2019 Jun 15;409:120-129. doi: 10.1016/j.neuroscience.2019.03.050. Epub 2019 Apr 30.
• [258] MK2 and Fas receptor contribute to the severity of CNS demyelination.PLoS One. 2014 Jun 25;9(6):e100363. doi: 10.1371/journal.pone.0100363. eCollection 2014.
• [259] (18)F-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis.J Nucl Med. 2020 May;61(5):757-763. doi: 10.2967/jnumed.119.229351. Epub 2019 Oct 25.
• [260] Immune Cell-Type Specific Ablation of Adapter Protein ADAP Differentially Modulates EAE.Front Immunol. 2019 Oct 1;10:2343. doi: 10.3389/fimmu.2019.02343. eCollection 2019.
• [261] GPR65 inhibits experimental autoimmune encephalomyelitis through CD4(+) T cell independent mechanisms that include effects on iNKT cells.Immunol Cell Biol. 2018 Feb;96(2):128-136. doi: 10.1111/imcb.1031. Epub 2017 Dec 19.
• [262] Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis.J Exp Med. 2019 Nov 4;216(11):2562-2581. doi: 10.1084/jem.20190377. Epub 2019 Aug 29.
• [263] The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.Int Immunol. 2014 Jul;26(7):369-81. doi: 10.1093/intimm/dxt056. Epub 2014 Jan 31.
• [264] Neuregulin1 modulation of experimental autoimmune encephalomyelitis (EAE).J Neuroimmunol. 2018 May 15;318:56-64. doi: 10.1016/j.jneuroim.2018.02.008. Epub 2018 Mar 11.
• [265] Systemic exposure to a single dose of ferucarbotran aggravates neuroinflammation in a murine model of experimental autoimmune encephalomyelitis.Int J Nanomedicine. 2019 Feb 15;14:1229-1240. doi: 10.2147/IJN.S189327. eCollection 2019.
• [266] IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.Front Immunol. 2018 Apr 30;9:802. doi: 10.3389/fimmu.2018.00802. eCollection 2018.
• [267] Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis.J Leukoc Biol. 2017 Feb;101(2):507-517. doi: 10.1189/jlb.3A0116-028RR. Epub 2016 Jul 21.
• [268] Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.Cell Immunol. 2018 Sep;331:38-48. doi: 10.1016/j.cellimm.2018.05.003. Epub 2018 May 14.
• [269] X-tra X: An escape to autoimmunity.J Clin Invest. 2019 Aug 12;129(9):3536-3538. doi: 10.1172/JCI130312. eCollection 2019 Aug 12.
• [270] Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.PLoS One. 2017 Jun 26;12(6):e0177472. doi: 10.1371/journal.pone.0177472. eCollection 2017.
• [271] Silencing Leukocyte Immunoglobulin-Like Receptor A1 in Monocytes Inhibits Inflammation in Mice with Multiple Sclerosis.Neuroimmunomodulation. 2019;26(2):93-101. doi: 10.1159/000495625. Epub 2019 Jan 23.
• [272] Peripheral sensory neuron injury contributes to neuropathic pain in experimental autoimmune encephalomyelitis.Sci Rep. 2017 Feb 9;7:42304. doi: 10.1038/srep42304.
• [273] Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.PLoS One. 2019 Mar 14;14(3):e0213508. doi: 10.1371/journal.pone.0213508. eCollection 2019.
• [274] Effect of catalpol on remyelination through experimental autoimmune encephalomyelitis acting to promote Olig1 and Olig2 expressions in mice.BMC Complement Altern Med. 2017 May 2;17(1):240. doi: 10.1186/s12906-017-1642-2.
• [275] Therapeutic Potential of Pien Tze Huang on Experimental Autoimmune Encephalomyelitis Rat.J Immunol Res. 2018 Feb 27;2018:2952471. doi: 10.1155/2018/2952471. eCollection 2018.
• [276] OTUB1 inhibits CNS autoimmunity by preventing IFN--induced hyperactivation of astrocytes.EMBO J. 2019 May 15;38(10):e100947. doi: 10.15252/embj.2018100947. Epub 2019 Apr 3.
• [277] Pannexin1 Channels Are Required for Chemokine-Mediated Migration of CD4+ T Lymphocytes: Role in Inflammation and Experimental Autoimmune Encephalomyelitis.J Immunol. 2016 May 15;196(10):4338-47. doi: 10.4049/jimmunol.1502440. Epub 2016 Apr 13.
• [278] Iron Drives T Helper Cell Pathogenicity by Promoting RNA-Binding Protein PCBP1-Mediated Proinflammatory Cytokine Production.Immunity. 2018 Jul 17;49(1):80-92.e7. doi: 10.1016/j.immuni.2018.05.008. Epub 2018 Jun 26.
• [279] FAM64A positively regulates STAT3 activity to promote Th17 differentiation and colitis-associated carcinogenesis.Proc Natl Acad Sci U S A. 2019 May 21;116(21):10447-10452. doi: 10.1073/pnas.1814336116. Epub 2019 May 6.
• [280] Thymic-Specific Serine Protease Limits Central Tolerance and Exacerbates Experimental Autoimmune Encephalomyelitis.J Immunol. 2017 Dec 1;199(11):3748-3756. doi: 10.4049/jimmunol.1700667. Epub 2017 Oct 23.
• [281] Rab32 connects ER stress to mitochondrial defects in multiple sclerosis.J Neuroinflammation. 2017 Jan 23;14(1):19. doi: 10.1186/s12974-016-0788-z.
• [282] TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.Front Immunol. 2018 Jan 22;9:15. doi: 10.3389/fimmu.2018.00015. eCollection 2018.
• [283] Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis.Sci Rep. 2019 Aug 12;9(1):11664. doi: 10.1038/s41598-019-48087-3.
• [284] RGC-32 regulates reactive astrocytosis and extracellular matrix deposition in experimental autoimmune encephalomyelitis.Immunol Res. 2018 Aug;66(4):445-461. doi: 10.1007/s12026-018-9011-x.
• [285] Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis.Mol Neurobiol. 2017 Aug;54(6):4820-4831. doi: 10.1007/s12035-016-0154-2. Epub 2016 Oct 6.
• [286] CD169 is a marker for highly pathogenic phagocytes in multiple sclerosis.Mult Scler. 2018 Mar;24(3):290-300. doi: 10.1177/1352458517698759. Epub 2017 Mar 9.
• [287] Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitis.Brain Behav Immun. 2018 Feb;68:197-210. doi: 10.1016/j.bbi.2017.10.018. Epub 2017 Oct 21.
• [288] T-cell activation RhoGTPase-activating protein plays an important role in T(H)17-cell differentiation.Immunol Cell Biol. 2017 Sep;95(8):729-735. doi: 10.1038/icb.2017.27. Epub 2017 May 2.
• [289] Adjuvant and antigenic properties of Mycobacterium avium subsp. paratuberculosis on experimental autoimmune encephalomyelitis.J Neuroimmunol. 2019 May 15;330:174-177. doi: 10.1016/j.jneuroim.2019.01.013. Epub 2019 Jan 23.
• [290] Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity.J Exp Med. 2013 Jul 1;210(7):1301-9. doi: 10.1084/jem.20121611.
• [291] Glucocorticoid-Induced Leucine Zipper: A Novel Anti-inflammatory Molecule.Front Pharmacol. 2019 Mar 27;10:308. doi: 10.3389/fphar.2019.00308. eCollection 2019.
• [292] Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis.Int J Mol Sci. 2019 Sep 4;20(18):4323. doi: 10.3390/ijms20184323.
• [293] AKT2 maintains brain endothelial claudin-5 expression and selective activation of IR/AKT2/FOXO1-signaling reverses barrier dysfunction.J Cereb Blood Flow Metab. 2020 Feb;40(2):374-391. doi: 10.1177/0271678X18817512. Epub 2018 Dec 21.
• [294] Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.Mol Neurobiol. 2017 May;54(4):2445-2457. doi: 10.1007/s12035-016-9840-3. Epub 2016 Mar 12.
• [295] MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis.Neurobiol Dis. 2019 May;125:154-162. doi: 10.1016/j.nbd.2019.01.019. Epub 2019 Jan 29.
• [296] Nitration of MOG diminishes its encephalitogenicity depending on MHC haplotype.J Neuroimmunol. 2017 Feb 15;303:1-12. doi: 10.1016/j.jneuroim.2016.11.008. Epub 2016 Nov 26.